Nanomolar [beta]-lactamase inhibitors
New carboxyphenyl-glycylboronic acid transition-state analog inhibitors, representative of a class of compounds effective against class C [beta]-lactamase AmpC. The new compounds improve inhibition by over two-orders of magnitude compared to analogous glycylboronic acids, with Ki values as low as 1 nM.
HOICHET BRIAN K [US]; PRATI FABRIO [IT]
Type of Offer:
« More Nanotech Patents